Abstract
Head and neck radiotherapy is accompanied by deleterious effects of radiation to healthy tissues. The clinical consequences of the effects of radiotherapy on the salivary glands include hyposalivation, deterioration of mucositis and taste loss, and the life-long threat of developing radiation caries and osteoradionecrosis. While mucositis and taste loss are reversible consequences that usually subside early postirradiation, hyposalivation is normally irreversible. This chapter focuses on the long-term effects of radiotherapy on the salivary glands and dentition. The clinical picture of xerostomia and xerostomia-related dental caries is described, and guidelines are given how to treat xerostomia and how to prevent dental caries.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Sreebny LM, Vissink A, eds. Dry mouth. The malevolent symptom: a clinical guide. Ames, Iowa: Wiley-Blackwell; 2010.
Ship JA, Fox PC, Baum BJ. Normal salivary gland function: how much saliva is enough? J Am Dent Assoc. 1991;122:63–69.
Dawes C, Odlum O. Salivary status in patients treated for head and neck cancer. J Can Dent Assoc. 2004;70:397–400.
Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc. 1987;115:581–584.
Hamlet S, Faull J, Klein B, Aref A, Fontanesi J, Stachler R et al. Mastication and swallowing in patients with postirradiation xerostomia. Int J Radiat Oncol Biol Phys. 1997;37:789–796.
Del Regato JA. Dental lesions observed after roentgen therapy in cancer of the buccal cavity, pharynx and larynx. Am J Roentgenol. 1939;42:404–410.
Frank RM, Herdly J, Philippe E. Acquired dental defects and salivary gland lesions after irradiation for carcinoma. J Am Dent Assoc. 1965;70:868–883.
Karmiol M, Walsh RF. Dental caries after radiotherapy of the oral regions. J Am Dent Assoc. 1975;91:838–845.
Jongebloed WL, ‘s-Gravenmade EJ, Retief DH. Radiation caries. A review and SEM study. Am J Dent. 1988;1:139–146.
Jansma J, Vissink A, Jongebloed WL. Natural and induced radiation caries. A SEM study. Am J Dent. 1993;6:130–136.
Mouly S, Salom M, Tillet Y et al. Management of xerostomia in older patients: a randomised controlled trial evaluating the efficacy of a new oral lubricant solution. Drugs Aging. 2007;24:957–965.
Mouly SJ, Orler JB, Tillet Y et al. Efficacy of a new oral lubricant solution in the management of psychotropic drug-induced xerostomia: a randomized controlled trial. J Clin Psychopharmacol. 2007;27:437–443.
Vissink A, De Jong HP, Busscher HJ. Wetting properties of human saliva and saliva substitutes. J Dent Res. 1986;65:1121–1124.
Johnson JT, Ferretti GA, Nethery WJ et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. New Eng J Med. 1993;329:390–395.
Vivino FB, Al-Hashimi I, Khan Z et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren’s syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Int Med. 1999;159:174–181.
Petrone D, Condemi JJ, Fife R et al. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren’s syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum. 2002;46:748–754.
Fife RS, Chase WF, Dore RK et al. Cevimeline for the treatment of xerostomia in patients with Sjögren’s syndrome: a randomized trial. Arch Int Med. 2002;162:1293–1300.
Jensen SB, Pedersen AML, Vissink A et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer 2010;18:1061–1079.
Chambers MS, Jones CU, Biel MA et al. Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia. Int J Radiat Oncol Biol Phys. 2007;69:1369–1376.
Wiseman LR, Faulds D. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Drugs. 1995;49:143–155.
Jedel E. Acupuncture in xerostomia – a systematic review. J Oral Rehabil. 2005;32:392–396.
Brennan MT, Shariff G, Lockhart PB et al. Treatment of xerostomia: a systematic review of therapeutic trials. Dent Clin North Am. 2002;46:847–856.
Regelink G, Vissink A, Reintsema H. Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence Int. 1998;29:383–388.
Epstein JB, Emerton S, Le ND, Stevenson-Moore P. A double-blind crossover trial of Oral Balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncol. 1999;35:132–137.
Zero DT. Dentifrices, mouthwashes, and remineralization/caries arrestment strategies. BMC Oral Health. 2006;6(Suppl 1):S9.
Ship JA, McCutcheon JA, Spivakovsky S et al. Safety and effectiveness of topical dry mouth products containing olive oil, betaine, and xylitol in reducing xerostomia for polypharmacy-induced dry mouth. J Oral Rehabil. 2007;34:724–732.
Hahnel S, Behr M, Handel G, Bürgers R. Saliva substitutes for the treatment of radiation-induced xerostomia – a review. Support Care Cancer. 2009;17:1331–1343.
Fox PC, Brennan M, Pillemer S et al. Sjögren’s syndrome: a model for dental care in the 21st century. J Am Dent Assoc. 1998;129:719–728.
Atkinson JC, Wu A. Salivary gland dysfunction: causes, symptoms, treatment. J Am Dent Assoc. 1994;125:409–416.
Fox PC. Management of dry mouth. Dental Clin North Am. 1997;41:863–876.
American Dental Association Council on Scientific Affairs. The use of dental radiographs: update and recommendations. J Am Dent Assoc. 2006;137:1304–1312.
Jansma J, Vissink A, ‘s-Gravenmade EJ. In vivo study on the prevention of post-radiation caries. Caries Res. 1989;23:172–178.
Kielbassa AM, Hinkelbein W, Hellwig E et al. Radiation-related damage to dentition. Lancet Oncol. 2006;7:326–335.
Chalmers JM. Minimal intervention dentistry: part 1. Strategies for addressing the new caries challenge in older patients. J Can Dent Assoc. 2006;72:427–433.
Anusavice KJ. Dental caries: risk assessment and treatment solutions for an elderly population. Compend Contin Educ Dent. 2002;23(10 Suppl):12–20.
Walsh L. Lifestyle impacts on oral health. In: Mount G, Hume W, eds. Preservation and restoration of tooth structure. Middlesbrough, UK: Knowledge Books and Software Ltd; 2005:83–110.
Van Loveren C. Sugar alcohols: what is the evidence for caries-preventive and caries-therapeutic effects? Caries Res. 2004;38:286–293.
Guggenheimer J, Moore PA. Xerostomia: etiology, recognition and treatment. J Am Dent Assoc. 2003;134:61–69.
Tanida T, Okamoto T, Okamoto A et al. Decreased excretion of antimicrobial proteins and peptides in saliva of patients with oral candidiasis. J Oral Pathol Med. 2003;32:586–594.
Daniels TE, Fox PC. Salivary and oral components of Sjogren’s syndrome. Rheum Dis Clin North Am. 1992;18:571–589.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Society for Imaging Informatics in Medicine
About this chapter
Cite this chapter
Vissink, A., Spijkervet, F.K.L., Brennan, M.T. (2010). Xerostomia and Dental Problems in the Head and Neck Radiation Patient. In: Olver, I. (eds) The MASCC Textbook of Cancer Supportive Care and Survivorship. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-1225-1_22
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1225-1_22
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-1224-4
Online ISBN: 978-1-4419-1225-1
eBook Packages: MedicineMedicine (R0)